These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 17160280)

  • 21. Prevalence of Trypanosoma cruzi antibodies in blood donors from Veracruz State, Mexico.
    Hernández-Romano P; Cámara-Contreras M; Bravo-Sarmiento E; López-Balderas N
    Transfusion; 2015 Mar; 55(3):647-56. PubMed ID: 25208459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Seroprevalence of Trypanosoma cruzi antibodies and associated risk factors among the population under 18 years of age in Veracruz, Mexico].
    Salazar PM; Rojas G; Bucio M; Cabrera M; García G; Ruiz A; Guevara Y; Tapia R
    Rev Panam Salud Publica; 2007 Aug; 22(2):75-82. PubMed ID: 17976273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Negative studies are helpful to compute the specificity of diagnostic tests: measuring Trypanosoma cruzi seroprevalence in Guanajuato, Mexico.
    Padilla-Raygoza N; Gamboa-León R; Ramirez-Sierra MJ; Dumonteil E; Buekens P; Ruiz-Paloalto ML; Diaz-Guerrero R
    BMC Res Notes; 2015 Oct; 8():614. PubMed ID: 26510987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trypanosoma cruzi infection associated with atypical clinical manifestation during the acute phase of the Chagas disease.
    Rangel-Gamboa L; López-García L; Moreno-Sánchez F; Hoyo-Ulloa I; Vega-Mémije ME; Mendoza-Bazán N; Romero-Valdovinos M; Olivo-Díaz A; Villalobos G; Martínez-Hernández F
    Parasit Vectors; 2019 Oct; 12(1):506. PubMed ID: 31666114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seroprevalence of Trypanosoma cruzi among children from Veracruz, Mexico: Epidemiological baseline for a control model based on Chagas disease active transmission.
    Pérez-Sánchez E; Montiel-Cruz R; Romero-Domínguez E; Pascacio-Bermúdez G; Báez-Hernández A; Díaz Del Castillo-Flores G; Correa-Morales F; Vázquez-Prokopec G; Manrique-Saide P; Che-Mendoza A; Meneses-Ruiz G; López-Martínez I; Jesús Sánchez M
    Biomedica; 2024 Mar; 44(1):92-101. PubMed ID: 38648342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Reproducibility of serological tests for the diagnosis of Trypanosoma cruzi infection in pregnant women in an endemic area of Santander, Colombia].
    Castellanos YZ; Cucunubá ZM; Flórez AC; Orozco-Vargas LC
    Biomedica; 2014; 34(2):198-206. PubMed ID: 24967925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Epidemiology of Chagas disease in four rural localities in Jaguaruana, State of Ceará: seroprevalence of infection, parasitemia and clinical characteristics].
    Borges-Pereira J; Sarquis O; Zauza PL; Britto C; Lima MM
    Rev Soc Bras Med Trop; 2008; 41(4):345-51. PubMed ID: 18853005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Trypanosoma cruzi infection with risk factors and electrocardiographic abnormalities in northeast Mexico.
    Molina-Garza ZJ; Rosales-Encina JL; Mercado-Hernández R; Molina-Garza DP; Gomez-Flores R; Galaviz-Silva L
    BMC Infect Dis; 2014 Mar; 14():117. PubMed ID: 24580840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrate study of a Bolivian population infected by Trypanosoma cruzi, the agent of Chagas disease.
    Brenière SF; Bosseno MF; Noireau F; Yacsik N; Liegeard P; Aznar C; Hontebeyrie M
    Mem Inst Oswaldo Cruz; 2002 Apr; 97(3):289-95. PubMed ID: 12048553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevalence of positive serology to Trypanosoma cruzi in patients with clinical diagnosis of dilated myocardiopathy in the state of Campeche].
    Alducin-Téllez C; Rueda-Villegas E; Medina-Yerbes I; Hernández O; López R; Peña-Hernández V; Monteón V
    Arch Cardiol Mex; 2011; 81(3):204-7. PubMed ID: 21975234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Humoral and cellular immune response of adults from northeastern Brazil with chronic Trypanosoma cruzi infection: depressed cellular immune response to T. cruzi antigen among Chagas' disease patients with symptomatic versus indeterminate infection.
    Cetron MS; Basilio FP; Moraes AP; Sousa AQ; Paes JN; Kahn SJ; Wener MH; Van Voorhis WC
    Am J Trop Med Hyg; 1993 Sep; 49(3):370-82. PubMed ID: 8372959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Description of chagas disease in the Valle de Iguala, Guerrero state, Mexico- Marco].
    Becerril-Flores MA; Valle-De La Cruz A
    Gac Med Mex; 2003; 139(6):539-44. PubMed ID: 14723049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do commercial serologic tests for Trypanosoma cruzi infection detect Mexican strains in women and newborns?
    Gamboa-León R; Gonzalez-Ramirez C; Padilla-Raygoza N; Sosa-Estani S; Caamal-Kantun A; Buekens P; Dumonteil E
    J Parasitol; 2011 Apr; 97(2):338-43. PubMed ID: 21506787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On the possibility of autochthonous Chagas disease in Roraima, Amazon region, Brazil, 2000-2001.
    Luitgards-Moura JF; Borges-Pereira J; Costa J; Zauza PL; Rosa-Freitas MG
    Rev Inst Med Trop Sao Paulo; 2005; 47(1):45-54. PubMed ID: 15729474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Biotic and abiotic determinants of seroprevalence of antibodies against Trypanosoma cruzi in Palmar de Bravo, Puebla, Mexico].
    Sosa-Jurado F; Zumaquero-Ríos JL; Reyes PA; Cruz-García A; Guzmán-Bracho C; Monteón VM
    Salud Publica Mex; 2004; 46(1):39-48. PubMed ID: 15053395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chagas disease and blood transfusion: an emerging issue in non-endemic countries].
    Assal A; Corbi C
    Transfus Clin Biol; 2011 Apr; 18(2):286-91. PubMed ID: 21440479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seroprevalence of Trypanosoma cruzi in kidney transplant donors and recipients in Mexico City.
    Rodríguez-Romo R; Morales-Buenrostro LE; Reyes PA; Gracida C; Medeiros M; Mancilla E; De Leo C; Alberú J
    Transpl Infect Dis; 2013 Dec; 15(6):639-44. PubMed ID: 23901935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood transfusion and iatrogenic risks in Mexico City. Anti-Trypanosoma cruzi seroprevalence in 43,048 blood donors, evaluation of parasitemia, and electrocardiogram findings in seropositive.
    Hernández-Becerril N; Mejía AM; Ballinas-Verdugo MA; Garza-Murillo V; Manilla-Toquero E; López R; Trevethan S; Cardenas M; Reyes PA; Hirayama K; Monteón VM
    Mem Inst Oswaldo Cruz; 2005 Apr; 100(2):111-6. PubMed ID: 16021296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Th-17 cytokines are associated with severity of Trypanosoma cruzi chronic infection in pediatric patients from endemic areas of Mexico.
    De Alba-Alvarado M; Salazar-Schettino PM; Jiménez-Álvarez L; Cabrera-Bravo M; García-Sancho C; Zenteno E; Vazquez-Antona C; Cruz-Lagunas A; Zúñiga J; Bucio-Torres MI
    Acta Trop; 2018 Feb; 178():134-141. PubMed ID: 29180164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The prevalence of Trypanosoma cruzi infection in blood donors in the state of Jalisco, Mexico].
    Trujillo Contreras F; Lozano Kasten F; Soto Gutiérrez MM; Hernández Gutiérrez R
    Rev Soc Bras Med Trop; 1993; 26(2):89-92. PubMed ID: 8128076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.